2m 2m 2m 2m 2m 2m 2m
Stryker (SYK)
NYSE
$308.39+$3.70 (+1.21%)
Price as of Jun 23, 2026 2:45 PM EDT- $116.8BMarket Cap
- -18.87%1-Year Change
- Medical DevicesIndustry
Stryker (SYK)
$308.39+$3.70 (+1.21%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 25.1B +11.16% | 22.6B +10.23% | 20.5B +11.11% | 18.4B +7.84% | |
Cost of Revenue | 9.1B +10.99% | 8.2B +9.61% | 7.4B +8.28% | 6.9B +11.91% | |
Gross Profit | 16.1B +11.25% | 14.4B +10.58% | 13.1B +12.78% | 11.6B +5.56% | |
Sales and Marketing Expense | 8.7B +12.57% | 7.7B +7.80% | 7.1B +10.44% | 6.5B +0.44% | |
Research and Development Expense | -1.6B +10.71% | -1.5B +5.62% | -1.4B -4.54% | -1.5B +17.73% | |
Depreciation and Amortization Expense | 461.0M +7.96% | 427.0M +8.65% | 393.0M +5.93% | 371.0M 0.00% | |
Total Operating Expenses | 11.2B +3.95% | 10.8B +17.24% | 9.2B +4.96% | 8.7B +4.21% | |
Operating Profit | 4.9B +32.53% | 3.7B -5.12% | 3.9B +36.85% | 2.8B +9.95% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -582.0M +46.97% | -396.0M +11.24% | -356.0M +5.64% | -337.0M 0.00% | |
Interest Income and Expense and Net | -582.0M +46.97% | -396.0M +11.24% | -356.0M +5.64% | -337.0M 0.00% | |
Total Nonoperating Income and Expense | 232.0M +217.77% | -197.0M -8.37% | -215.0M +36.08% | -158.0M -47.85% | |
Income before Taxes | 4.5B +29.27% | 3.5B -4.93% | 3.7B +36.90% | 2.7B +17.62% | |
Income Taxes | 1.3B +154.11% | 499.0M -1.77% | 508.0M +56.31% | 325.0M +13.24% | |
Extraordinary Items | 170.0M -82.60% | 977.0M N/A | 0 -100.00% | 47.0M -82.20% | |
Net Income | 3.2B +8.45% | 3.0B -5.43% | 3.2B +34.22% | 2.4B +18.25% | |
Net Income from Continuing Operations Applicable to Common | 4.5B +29.27% | 3.5B -4.93% | 3.7B +36.90% | 2.7B +17.62% | |
Basic EPS and Net Income | 8.49 +8.02% | 7.86 -5.76% | 8.34 +33.87% | 6.23 +17.77% | |
Diluted EPS and Net Income | 8.40 +8.25% | 7.76 -5.94% | 8.25 +33.71% | 6.17 +18.43% | |
Basic Weighted Average Shares | 382.2M +0.31% | 381.0M +0.37% | 379.6M +0.37% | 378.2M +0.32% | |
Diluted Weighted Average Shares | 386.5M +0.23% | 385.6M +0.50% | 383.7M +0.39% | 382.2M -0.03% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.0B +9.83% | 3.7B +22.92% | 3.0B +61.12% | 1.8B -37.36% | |
Short-Term Investments | 89.0M -2.20% | 91.0M +10.98% | 82.0M -2.38% | 84.0M +12.00% | |
Cash and Cash Equivalents and Short-Term Investments | 4.1B +9.54% | 3.7B +22.60% | 3.1B +58.35% | 1.9B -36.14% | |
Total Current Assets | 14.8B -0.62% | 14.8B +18.61% | 12.5B +21.83% | 10.3B +2.58% | |
Accumulated Depreciation | 3.7B +13.17% | 3.2B +3.39% | 3.1B +10.37% | 2.8B +6.38% | |
Property and Plant and Equipment and Net | 3.9B +12.41% | 3.4B +7.25% | 3.2B +8.25% | 3.0B +4.84% | |
Total Long-Term Assets | 3.1B +17.10% | 2.7B +0.41% | 2.7B +8.48% | 2.5B +8.88% | |
Total Assets | 47.8B +11.34% | 43.0B +7.66% | 39.9B +8.21% | 36.9B +6.51% | |
Income Taxes Payable | 820.0M -7.66% | 888.0M -7.31% | 958.0M +2.68% | 933.0M -15.57% | |
Total Short-Term Debt | 1.0B -29.03% | 1.4B -32.71% | 2.1B +75.82% | 1.2B +16,914.29% | |
Total Current Liabilities | 7.8B +2.34% | 7.6B -3.85% | 7.9B +25.67% | 6.3B +38.56% | |
Total Long-Term Debt | 14.9B +21.91% | 12.2B +11.81% | 10.9B -8.06% | 11.9B -4.93% | |
Total Long-Term Liabilities | 2.4B +8.47% | 2.2B +13.16% | 1.9B +31.56% | 1.5B -19.40% | |
Total Liabilities | 25.4B +13.82% | 22.3B +4.78% | 21.3B +5.19% | 20.3B +2.60% | |
Retained Earnings | 20.5B +10.49% | 18.5B +10.48% | 16.8B +13.59% | 14.8B +9.53% | |
Total Stockholders Equity | 22.4B +8.66% | 20.6B +10.98% | 18.6B +11.90% | 16.6B +11.69% | |
Total Shares Outstanding | 382.5M +0.29% | 381.4M +0.34% | 380.1M +0.37% | 378.7M +0.32% | |
Cash Flow | |||||
Cash from Operating Activities | 5.0B +18.91% | 4.2B +14.31% | 3.7B +41.43% | 2.6B -19.58% | |
Capital Expenditures | 761.0M +0.79% | 755.0M +31.30% | 575.0M -2.21% | 588.0M +12.00% | |
Cash from Investing Activities | -4.9B +62.20% | -3.0B +211.85% | -962.0M -67.10% | -2.9B +240.40% | |
Dividends Paid | 1.3B +5.33% | 1.2B +7.02% | 1.1B +8.37% | 1.1B +10.63% | |
Cash from Financing Activities | 113.0M +121.52% | -525.0M -67.06% | -1.6B +112.82% | -749.0M -68.33% | |
Financials Ratio | |||||
Gross Margin | 63.96% +0.09% | 63.91% +0.32% | 63.70% +1.51% | 62.76% -2.11% | |
Operating Margin | 19.47% +19.23% | 16.33% -13.92% | 18.97% +23.17% | 15.40% +1.95% | |
Return on Assets | 7.15% -1.02% | 7.22% -12.38% | 8.24% +24.99% | 6.59% +14.03% | |
Return on Equity | 15.08% -1.19% | 15.26% -15.12% | 17.98% +20.06% | 14.97% +4.99% | |
Revenue Growth | 11.16% +9.06% | 10.23% -7.89% | 11.11% +41.69% | 7.84% -59.20% | |
Current Ratio | 1.89 -2.89% | 1.95 +23.35% | 1.58 -3.05% | 1.63 -25.97% | |
Cash Ratio | 0.51 +7.32% | 0.48 +27.83% | 0.38 +28.20% | 0.29 -54.79% | |
Debt-to-Equity Ratio | 0.71 +7.34% | 0.66 -5.71% | 0.70 -11.00% | 0.79 -6.38% | |
Debt-to-Assets Ratio | 0.33 +4.77% | 0.32 -2.83% | 0.33 -7.97% | 0.35 -1.80% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow